[Vitiligo with Koebner phenomenon in a patient with multiple sclerosis treated with alemtuzumab]

Rev Neurol. 2018 Jun 1;66(11):395-396.
[Article in Spanish]

Abstract

Vitiligo con fenomeno de Koebner en una paciente con esclerosis multiple tratada con alemtuzumab.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Alemtuzumab / adverse effects*
  • Alemtuzumab / therapeutic use
  • Autoimmunity / drug effects
  • CD52 Antigen / immunology
  • Female
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Melanocytes / immunology
  • Melanocytes / pathology
  • Multiple Sclerosis, Relapsing-Remitting / complications
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Skin / injuries
  • Vitiligo / chemically induced*
  • Vitiligo / immunology

Substances

  • CD52 Antigen
  • CD52 protein, human
  • Immunosuppressive Agents
  • Alemtuzumab